自身免疫性疾病流行病学研究进展

方心宇; 冷瑞雪; 范引光; 张勤; 潘海峰; 叶冬青

doi:10.16462/j.cnki.zhjbkz.2021.08.001

自身免疫性疾病流行病学研究进展

doi: 10.16462/j.cnki.zhjbkz.2021.08.001

230032 合肥，安徽医科大学公共卫生学院流行病与卫生统计学系，炎症免疫性疾病安徽省实验室

基金项目:

国家自然科学基金 82073652

国家自然科学基金 81872693

国家自然科学基金 81673258

详细信息

通讯作者:
叶冬青，E-mail: ydq@ahmu.edu.cn

中图分类号: R593.2
计量
- 文章访问数: 3080
- HTML全文浏览量: 3167
- PDF下载量: 1480
- 被引次数: 0
出版历程
- 收稿日期: 2021-06-28
- 修回日期: 2021-07-17
- 网络出版日期: 2021-08-24
- 刊出日期: 2021-08-10

Research advances in the epidemiology of autoimmune diseases

Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei 230032, China

Funds:

National Natural Science Foundation of China 82073652

National Natural Science Foundation of China 81872693

National Natural Science Foundation of China 81673258

More Information

Corresponding author: YE Dong-qing, E-mail: ydq@ahmu.edu.cn

摘要

摘要: 自身免疫性疾病(autoimmune diseases, AIDs)是由免疫系统对自身抗原失去免疫耐受，进一步诱发组织损伤和炎症反应并最终导致靶器官受损的一类慢性疾病。这类疾病确切的病因及发病机制至今未明，目前尚不能彻底治愈，极大地影响了患者的劳动力和生活质量，甚至威胁患者生命，消耗大量卫生资源，已成为影响人类健康的重要的公共卫生问题。在过去几十年，AIDs的流行病学研究取得了有目共睹的成就，极大促进了AIDs的诊断、治疗、预后及病因研究。本文对AIDs的流行病学研究进展进行了概述，旨在为AIDs防控策略的制定及未来的研究方向提供一些新的见解和参考。
- 自身免疫性疾病 /
- 流行病学 /
- 研究进展
Abstract: Autoimmune diseases (AIDs) are a heterogeneous group of diseases characterized by the loss of self-tolerance, which leads to prolonged inflammation and subsequent tissue damage. The exact etiology and pathogenesis of this type of disease have not been fully elucidated. As incurable diseases, AIDs significantly affects the labor force and the quality of life of patients and even threatens the lives of cases. Autoimmune diseases have become one of the major health problems worldwide, constituting a heavy burden to society and are often debilitating and disabling for affected individuals. In the past decades, epidemiological research of AIDs has made remarkable achievements, which greatly promoted the diagnosis, treatment, prognosis, and etiology of AIDs. This article provides an overview of the development of AIDs epidemiological research, aiming to offer some new insights and references for the formulation of AIDs prevention and control strategies and future research directions.
- Autoimmune disease /
- Epidemiology /
- Research advance

HTML全文

参考文献(17)

[1]	Zhang X, Liu C, Nepal S, et al. A hybrid approach for scalable sub-tree anonymization over big data using MapReduce on cloud[J]. J Comput Syst Sci, 2014, 80(5): 1008-1020. DOI: 10.1016/j.jcss.2014.02.007.
[2]	Theofilopoulos AN, Kono DH, Baccala R. The multiple pathways to autoimmunity[J]. Nat Immunol, 2017, 18(7): 716-724. DOI: 10.1038/ni.3731.
[3]	Chang C. Autoimmunity: from black water fever to regulatory function[J]. J Autoimmun, 2014, 48-49: 1-9. DOI: 10.1016/j.jaut.2013.12.019.
[4]	叶冬青. 红斑狼疮[M]. 北京: 人民卫生出版社, 2006. Ye DQ. Lupus erythematosus[M]. Beijing: People's Medical Publishing House, 2006.
[5]	叶冬青, 倪进发, 郑惠玲, 等. 安徽省准南市潘集区常见结缔组织病的流行病学调查. [J]. 中国人兽共患病杂志, 1993, 9: 14-15. Ye DQ, Ni JF, Zheng HL, et al. Epidemiological survey of common connective tissue diseases in Panji District, Zhunnan City, Anhui Province. [J]. Chin J Zoohoses, 1993, 9: 14-15.
[6]	Maahs DM, West NA, Lawrence JM, et al. Epidemiology of type 1 diabetes[J]. Endocrinol Metab Clin North Am, 2010, 39(3): 481-497. DOI: 10.1016/j.ecl.2010.05.011.
[7]	Darwish MJ, Armenian HK. A case-control study of rheumatoid arthritis in Lebanon[J]. Int J Epidemiol, 1987, 16(3): 420-424. DOI: 10.1093/ije/16.3.420.
[8]	Zou YF, Feng CC, Zhu JM, et al. Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province[J]. Rheumatol Int, 2014, 34(3): 347-356. DOI: 10.1007/s00296-013-2902-1.
[9]	叶冬青. 皮肤病流行病学[M]. 北京: 人民卫生出版社, 2001. Ye DQ. Skin epidemiology[M]. Beijing: People's Medical Publishing House, 2001.
[10]	Han JW, Zheng HF, Cui Y, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus[J]. Nat Genet, 2009, 41(11): 1234-1237. DOI: 10.1038/ng.472.
[11]	Leng RX, Di DS, Ni J, et al. Identification of new susceptibility loci associated with rheumatoid arthritis[J]. Ann Rheum Dis, 2020, 79(12): 1565-1571. DOI: 10.1136/annrheumdis-2020-217351.
[12]	Wu J, Zhang TP, Zhao YL, et al. Decreased H19, GAS5, and linc0597 expression and association analysis of related gene polymorphisms in rheumatoid arthritis[J]. Biomolecules, 2019, 10(1): 55. DOI: 10.3390/biom10010055.
[13]	Tahvildari M, Dana R. Low-Dose IL-2 therapy in transplantation, autoimmunity, and inflammatory diseases[J]. J Immunol, 2019, 203(11): 2749-2755. DOI: 10.4049/jimmunol.1900733.
[14]	Murdaca G, Tonacci A, Negrini S, et al. Emerging role of vitamin D in autoimmune diseases: an update on evidence and therapeutic implications[J]. autoimmun Rev, 2019, 18(9): 102350. DOI: 10.1016/j.autrev.2019.102350.
[15]	Li H, Hu F, Zhang Y, et al. Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network Meta-analysis[J]. J Neurol, 2020, 267(12): 3489-3498. DOI: 10.1007/s00415-019-09395-w.
[16]	Samoilova IG, Rotkank MA, Kudlay DA, et al. A prognostic model of cognitive impairment in patients with type 1 diabetes mellitus[J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2020, 120(3): 19-22. DOI: 10.17116/jnevro202012003119.
[17]	Norgeot B, Glicksberg BS, Trupin L, et al. Assessment of a deep learning model based on electronic health record data to forecast clinical outcomes in patients with rheumatoid arthritis[J]. JAMA Netw Open, 2019, 2(3): e190606. DOI: 10.1001/jamanetworkopen.2019.0606.